An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data
ABSTRACT Introduction We aim to assess HPV vaccine administration among privately insured populations before and during the COVID‐19 pandemic in the United States and stratify the assessments by demographic and geographic characteristics. Methods Using the Merative MarketScan Commercial Claims and E...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Cancer Medicine |
| Online Access: | https://doi.org/10.1002/cam4.70761 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849724693269970944 |
|---|---|
| author | Milkie Vu Jingjing Li Kai Hong Jennifer W. Kaminski Bo‐Hyun Cho Yoonjae Kang |
| author_facet | Milkie Vu Jingjing Li Kai Hong Jennifer W. Kaminski Bo‐Hyun Cho Yoonjae Kang |
| author_sort | Milkie Vu |
| collection | DOAJ |
| description | ABSTRACT Introduction We aim to assess HPV vaccine administration among privately insured populations before and during the COVID‐19 pandemic in the United States and stratify the assessments by demographic and geographic characteristics. Methods Using the Merative MarketScan Commercial Claims and Encounters Database, we estimated monthly and yearly HPV vaccine administration among people aged 9–26 from 2019 to 2022, measured as the proportion of the enrolled population who received ≥ 1 dose of HPV vaccine during that month or year, and their relative percent change from 2020 to 2022, compared to the same period in 2019, overall and stratified by age group, sex, and urbanicity. Results HPV vaccine administration in 2020, 2021, and 2022 was lower than in 2019 and continued to decline for all age groups. The relative percent change in rate in 2022 relative to 2019 was −6.0% among children, −38.3% among adolescents, and −42.5% among young adults. The patterns were similar across subgroups, with certain disparities in magnitude. By subpopulations, the highest percent declines in 2022 relative to 2019 in each age group were observed among children in rural areas (−13.5%), male adolescents (−39.8%), and young adults in rural areas (−46.0%). Conclusion During the COVID‐19 pandemic, HPV vaccine administration dropped substantially and had not exceeded the pre‐pandemic levels by the end of 2022, with larger declines seen among male adolescents and young adults in rural areas. Our results highlight the need for continuing monitoring and targeted intervention strategies to improve HPV vaccine administration. |
| format | Article |
| id | doaj-art-800d4606348b43dc94d214d48c67e888 |
| institution | DOAJ |
| issn | 2045-7634 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj-art-800d4606348b43dc94d214d48c67e8882025-08-20T03:10:40ZengWileyCancer Medicine2045-76342025-03-01146n/an/a10.1002/cam4.70761An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims DataMilkie Vu0Jingjing Li1Kai Hong2Jennifer W. Kaminski3Bo‐Hyun Cho4Yoonjae Kang5Department of Preventive Medicine, Feinberg School of Medicine Northwestern University Chicago Illinois USADepartment of Behavior, Social, and Health Education Sciences, Rollins School of Public Health Emory University Atlanta Georgia USAOffice of Policy, Performance, and Evaluation Centers for Disease Control and Prevention Atlanta Georgia USAOffice of Policy, Performance, and Evaluation Centers for Disease Control and Prevention Atlanta Georgia USAThe National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Atlanta Georgia USAThe National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Atlanta Georgia USAABSTRACT Introduction We aim to assess HPV vaccine administration among privately insured populations before and during the COVID‐19 pandemic in the United States and stratify the assessments by demographic and geographic characteristics. Methods Using the Merative MarketScan Commercial Claims and Encounters Database, we estimated monthly and yearly HPV vaccine administration among people aged 9–26 from 2019 to 2022, measured as the proportion of the enrolled population who received ≥ 1 dose of HPV vaccine during that month or year, and their relative percent change from 2020 to 2022, compared to the same period in 2019, overall and stratified by age group, sex, and urbanicity. Results HPV vaccine administration in 2020, 2021, and 2022 was lower than in 2019 and continued to decline for all age groups. The relative percent change in rate in 2022 relative to 2019 was −6.0% among children, −38.3% among adolescents, and −42.5% among young adults. The patterns were similar across subgroups, with certain disparities in magnitude. By subpopulations, the highest percent declines in 2022 relative to 2019 in each age group were observed among children in rural areas (−13.5%), male adolescents (−39.8%), and young adults in rural areas (−46.0%). Conclusion During the COVID‐19 pandemic, HPV vaccine administration dropped substantially and had not exceeded the pre‐pandemic levels by the end of 2022, with larger declines seen among male adolescents and young adults in rural areas. Our results highlight the need for continuing monitoring and targeted intervention strategies to improve HPV vaccine administration.https://doi.org/10.1002/cam4.70761 |
| spellingShingle | Milkie Vu Jingjing Li Kai Hong Jennifer W. Kaminski Bo‐Hyun Cho Yoonjae Kang An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data Cancer Medicine |
| title | An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data |
| title_full | An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data |
| title_fullStr | An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data |
| title_full_unstemmed | An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data |
| title_short | An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID‐19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data |
| title_sort | ecological analysis of hpv vaccination in the united states before and during the covid 19 pandemic by age sex and urbanicity using private insurance claims data |
| url | https://doi.org/10.1002/cam4.70761 |
| work_keys_str_mv | AT milkievu anecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT jingjingli anecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT kaihong anecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT jenniferwkaminski anecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT bohyuncho anecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT yoonjaekang anecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT milkievu ecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT jingjingli ecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT kaihong ecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT jenniferwkaminski ecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT bohyuncho ecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata AT yoonjaekang ecologicalanalysisofhpvvaccinationintheunitedstatesbeforeandduringthecovid19pandemicbyagesexandurbanicityusingprivateinsuranceclaimsdata |